1. Home
  2. PMAX vs NBY Comparison

PMAX vs NBY Comparison

Compare PMAX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

BUY

Current Price

$3.31

Market Cap

4.5M

Sector

N/A

ML Signal

BUY

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.21

Market Cap

6.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
NBY
Founded
2019
2000
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
6.3M
IPO Year
2024
2007

Fundamental Metrics

Financial Performance
Metric
PMAX
NBY
Price
$3.31
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
132.3K
Earning Date
09-23-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$4,799,100.00
$10,302,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
N/A
$47.02
Revenue Growth
N/A
390.34
52 Week Low
$1.56
$0.46
52 Week High
$25.44
$4.44

Technical Indicators

Market Signals
Indicator
PMAX
NBY
Relative Strength Index (RSI) 74.38 57.09
Support Level $1.56 $1.00
Resistance Level $3.04 $1.11
Average True Range (ATR) 0.29 0.10
MACD 0.16 0.03
Stochastic Oscillator 97.77 97.26

Price Performance

Historical Comparison
PMAX
NBY

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: